Asia-Pacific: Hiring the Right Healthtech CFO Can Be Tough; It…
Robert Hall of Hong Kong-based executive recruitment specialist Ardent Search highlights the key traits and experiences that Asian biotech and medtech…
Tagged with Biotech
China: The Pharma Deals Keep Coming
The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO listing in Hong Kong, InventisBio…
Chinese Biotech Strategies: Biologics or Small Molecules
While the vast majority of the global pharma market still comprises small molecule drugs, the biologics sector has grown rapidly since its inception…
Chinese Biotech Strategies: The Pros & Cons of In-Licensing
Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs have seen in-licensing as a shortcut to establishing their own portfolios…
US Biotech Commercialisation Strategies: How Karyopharm &…
With US still the reigning global champion in biotech innovation, the dynamic and vibrant biopharma ecosystem in the world’s largest healthcare…
Joong Myung Cho – Chairman & CEO, CrystalGenomics,…
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery platform, key growth factors, highly…
Michael G. Kauffman – Founder & CEO, Karyopharm…
Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with his wife, the approval journey of key product…
China Pharma News Roundup September 2020
The latest from Chinese pharma, including a setback for CanSinoBIO’s Canadian COVID-19 vaccine trial, Bayer’s new Beijing manufacturing plant, and…
Kerry Blanchard – CEO, Everest Medicines, China
Dr Kerry Blanchard explains why he took on the challenge of becoming CEO of Chinese biotech Everest Medicines and how Everest’s internationalist…
Biotech Spotlight: Alphamab Oncology, China
Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein engineering company with the ultimate dream of becoming, as many Chinese…
China Pharma News Roundup August 2020
A roundup of the latest news from Chinese pharma, including Big Pharma players losing out in the latest round of domestic procurement bidding, updates…
Company Spotlight: I-Mab Biopharma
The only company in our Summer 2020 edition of InFocus: 5 Biotechs to Watch in China to be helmed by a non-founding CEO, I-Mab Biopharma has advanced…
